Literature DB >> 21840158

Effects of corticotropin-releasing hormone receptor antagonists on the ethanol-induced increase of dynorphin A1-8 release in the rat central amygdala.

Minh P Lam1, Christina Gianoulakis.   

Abstract

Neurons in the central amygdala (CeA) co-express dynorphin and corticotropin-releasing hormone (CRH). Moreover, the activity of both the CRH and dynorphin systems in CeA is altered by alcohol treatments, effects suggesting interactions between the CRH and dynorphin systems. Thus, the objectives of the present study were to investigate the effects of (1) activating CRH receptors (CRHRs) by microinjection of CRH in CeA and (2) blocking CRHRs by local microinjections of CRHR antagonists in the CeA on the alcohol-induced changes in the extracellular concentrations of dynorphin A1-8 with in vivo microdialysis experiments. Microdialysis probes with a microinjection port were implanted in the CeA of alcohol-naïve Sprague-Dawley rats. Microinjections of CRH or antalarmin, a CRH receptor type 1 (CRHR1) antagonist, or anti-sauvagine-30, a CRH receptor type 2 (CRHR2) antagonist, at the level of CeA were followed by an intraperitoneal injection of either saline or 2.8 g ethanol/kg body weight. The content of dynorphin A1-8 was determined in dialyzate samples obtained prior to and following the various treatments using a specific radioimmunoassay. Activation of CRHRs in CeA induced an increase in the extracellular concentrations of dynorphin A1-8. Moreover, acute alcohol administration increased the extracellular concentrations of dynorphin A1-8 in CeA, an effect that was attenuated by blocking CRHR2 with anti-sauvagine-30 microinjection but not blocking CRHR1 with antalarmin microinjection. Therefore, the findings suggest an interaction between the CRH and dynorphin A1-8 systems at the level of CeA in response to acute alcohol exposure.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840158     DOI: 10.1016/j.alcohol.2011.05.001

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  16 in total

1.  Synergistic blockade of alcohol escalation drinking in mice by a combination of novel kappa opioid receptor agonist Mesyl Salvinorin B and naltrexone.

Authors:  Yan Zhou; Rachel Saylor Crowley; Konrad Ben; Thomas E Prisinzano; Mary Jeanne Kreek
Journal:  Brain Res       Date:  2017-03-02       Impact factor: 3.252

2.  Effects of voluntary alcohol drinking on corticotropin-releasing factor and preprodynorphin mRNA levels in the central amygdala of Sardinian alcohol-preferring rats.

Authors:  Yan Zhou; Giancarlo Colombo; Gian Luigi Gessa; Mary Jeanne Kreek
Journal:  Neurosci Lett       Date:  2013-09-08       Impact factor: 3.046

3.  mTORC1 pathway is involved in the kappa opioid receptor activation-induced increase in excessive alcohol drinking in mice.

Authors:  Yan Zhou; Yupu Liang; Mary Jeanne Kreek
Journal:  Pharmacol Biochem Behav       Date:  2020-05-26       Impact factor: 3.533

Review 4.  Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.

Authors:  Rachel I Anderson; Howard C Becker
Journal:  Alcohol Clin Exp Res       Date:  2017-06-05       Impact factor: 3.455

5.  Coordinate regulation of noradrenergic and serotonergic brain regions by amygdalar neurons.

Authors:  T A Retson; E J Van Bockstaele
Journal:  J Chem Neuroanat       Date:  2013-05-04       Impact factor: 3.052

6.  Interaction of CRF and kappa opioid systems on GABAergic neurotransmission in the mouse central amygdala.

Authors:  Maenghee Kang-Park; Brigitte L Kieffer; Amanda J Roberts; George R Siggins; Scott D Moore
Journal:  J Pharmacol Exp Ther       Date:  2015-09-08       Impact factor: 4.030

Review 7.  Involvement of Activated Brain Stress Responsive Systems in Excessive and "Relapse" Alcohol Drinking in Rodent Models: Implications for Therapeutics.

Authors:  Yan Zhou; Mary Jeanne Kreek
Journal:  J Pharmacol Exp Ther       Date:  2018-04-18       Impact factor: 4.030

Review 8.  Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment.

Authors:  Nicole A Crowley; Thomas L Kash
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-01-12       Impact factor: 5.067

9.  Combination of Clinically Utilized Kappa-Opioid Receptor Agonist Nalfurafine With Low-Dose Naltrexone Reduces Excessive Alcohol Drinking in Male and Female Mice.

Authors:  Yan Zhou; Mary Jeanne Kreek
Journal:  Alcohol Clin Exp Res       Date:  2019-05-02       Impact factor: 3.455

Review 10.  Influence of stress associated with chronic alcohol exposure on drinking.

Authors:  Howard C Becker
Journal:  Neuropharmacology       Date:  2017-04-19       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.